Sigma-Aldrich Signs Agreement with SouthWest NanoTechnologies to Distribute SWeNT® Single-Wall Carbon Nanotubes
News Dec 04, 2008
Sigma-Aldrich and SouthWest NanoTechnologies Inc. (SWeNT) have announced that they have signed an agreement under which Sigma-Aldrich will distribute SWeNT's single-wall carbon nanotubes to the research and development community.
Under the terms of the agreement, Sigma-Aldrich will exclusively distribute research quantities of SWeNT® CG 100, SWeNT® SG 65 and SWeNT® SG 76 single-wall nanotubes globally through its Aldrich® division.
SWeNT will continue to work closely with industry partners to deliver commercial quantities of the materials and focus on commercial application development and large-scale production.
Single-wall carbon nanotubes consist of a hollow cylinder of carbon with a diameter equal to approximately one nanometer -- a billionth of a meter. Due to their unusual structure, single-wall nanotubes exhibit extraordinary optical and electronic properties, tremendous strength and flexibility, and high thermal and chemical stability.
"There are significant global market opportunities for single-wall carbon nanotubes, and Sigma-Aldrich has a world-class distribution network. This agreement will provide the best possible products and service to the research and development community, which is incorporating SWeNT carbon nanotubes into innovative, emerging technologies," said SWeNT CEO David Arthur.
"In our role as a leading producer of high-quality single-wall nanotubes, we are committed to being an innovative partner in Sigma-Aldrich's continued development and creative applications. This agreement is key to reaching that goal."
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Nanotechnology Detects Molecular Biomarker for OsteoarthritisNews
For the first time, scientists have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology. This preclinical study used a solid-state nanopore sensor as a tool for the analysis of hyaluronic acid.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018